Komori
Earnings9267Genky DrugStores Co.,Ltd.Retail

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending June 2026 (Japanese GAAP, Consolidated)

For the nine months ended 20 March 2026, revenue increased 9.7% year on year and operating profit increased 17.3%. The full-year earnings and dividend forecasts remain unchanged from the latest published forecasts.

Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
17.3
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter21 June 2025 to 20 March 2026ConsolidatedJapanese GAAP
Net Sales161,710¥ millionYear on year +9.7%Progress 73.1%
Operating profit8,022¥ millionYear on year +17.3%Progress 72.6%
Ordinary income8,168¥ millionYear on year +15.9%Progress 72.9%
Net income attributable to owners of the parent5,621¥ millionYear on year +15.4%Progress 71.6%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥184.61
Financial position at period-end
Total assets142,340¥ million
of which net assets 59,090 ¥ millionEquity ratio 41.4%vs. prior year-end -0.4pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥221,200 million (YoY +10.2%)
Operating profit¥11,050 million (YoY +14.4%)
Ordinary income¥11,200 million (YoY +13.1%)
Net income¥7,850 million (YoY +11.1%)
Annual Dividend Forecast¥13.00 → ¥13.00(0.0%)
Factors Behind Changes in Business Performance

The company worked to increase regional market share and build dominant areas through concentrated store openings, pursue low-cost operations, and discount essential goods.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares ¥2 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥8 million
Depreciation and amortization¥5,162 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End31,031,568 Shares
Treasury Shares at Period-End532,069 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered21 June 2025 to 20 March 2026
Net Sales¥161,710 million (YoY +9.7%)
Operating profit¥8,022 million (YoY +17.3%)
Ordinary income¥8,168 million (YoY +15.9%)
Profit attributable to owners of the parent¥5,621 million (YoY +15.4%)
Net income per share¥184.61
Equity ratioEnd of the current fiscal period 41.4 / End of previous period 41.8
Total assets¥142,340 million
Net assets¥59,090 million
Full-year earnings forecastNet Sales ¥221,200 million (YoY +10.2%) / Operating profit ¥11,050 million (YoY +14.4%) / Ordinary income ¥11,200 million (YoY +13.1%) / Net income ¥7,850 million (YoY +11.1%)
Annual Dividend Forecast¥13.00 → ¥13.00(0.0%)
Depreciation and amortization¥5,162 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares ¥2 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥8 million
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End31,031,568 Shares
Treasury Shares at Period-End532,069 Shares
Factors Behind Changes in Business PerformanceThe company worked to increase regional market share and build dominant areas through concentrated store openings, pursue low-cost operations, and discount essential goods.
Items this document does not state (14)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company stated that, amid continued global uncertainty, rising prices for goods and services, and consumers' preference for saving, it worked to increase regional market share through concentrated store openings, pursue low-cost operations, and discount essential goods.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending June 2026 (Japanese GAAP, Consolidated) | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori